Vaso-Occlusive Pain Management in a Patient With Sickle Cell Disease Associated With Moyamoya Syndrome

被引:0
|
作者
Mills, Drezelle [1 ,2 ]
Wang, Annie [3 ]
Dubson, Iya [2 ]
机构
[1] St Georges Univ, Internal Med, Sch Med, St Georges, Grenada
[2] Kings Cty Hosp Ctr, Internal Med, Brooklyn, NY 11203 USA
[3] State Univ New York Downstate Hlth Sci Univ, Internal Med, Brooklyn, NY USA
关键词
pain management; vaso-occlusive pain; hypotension; sickle cell disease; moyamoya syndrome;
D O I
10.7759/cureus.23667
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Moyamoya syndrome in a sickle cell disease patient may be a difficult task to manage in the setting of a vaso-occlusive pain crisis. Maintaining stable blood pressure is necessary to prevent stroke as both hypertension and hypotension can be detrimental to the patient, leading to hemorrhagic and ischemic stroke, respectively. Opioid management for pain control in such patients must be taken into consideration. Because every patient is unique, opioid regimens should he optimized to relieve patients' specific pain while also practicing non-maleficence in preventing hypotension and strokes.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Temperature and Humidity Effects on Acute Vaso-Occlusive Pain Episodes in Sickle Cell Disease
    El Rassi, Fuad
    Randall, Eldrida
    Stein, Sidney F.
    Khoury, Hanna Jean
    Eckman, James R.
    McLemore, Morgan L.
    BLOOD, 2015, 126 (23)
  • [42] Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis
    Hardwick, WE
    Givens, TG
    Monroe, KW
    King, WD
    Lawley, D
    PEDIATRIC EMERGENCY CARE, 1999, 15 (03) : 179 - 182
  • [43] Antibiotics to modify sickle cell disease vaso-occlusive crisis?
    Stewart, Connor
    Jang, Tim
    Mo, George
    Mohamed, Nader
    Poplawska, Maria
    Egini, Ogechukwu
    Dutta, Dibyendu
    Lim, Seah H.
    BLOOD REVIEWS, 2021, 50
  • [44] A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
    Wood, David K.
    Soriano, Alicia
    Mahadevan, L.
    Higgins, John M.
    Bhatia, Sangeeta N.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (123)
  • [45] Vaso-occlusive manifestations in a patient with sickle cell-hemoglobin E (HbSE) disease
    Gürkan, E
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (02) : 149 - 149
  • [46] Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    Jacob, E
    Beyer, JE
    Miaskowski, C
    Savedra, M
    Treadwell, M
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (04) : 392 - 400
  • [47] Changes in Regional Oxygenation At the Site of Sickle Cell Vaso-Occlusive Pain
    Kato, Roberta Miyeko
    Nord, Anne
    McGuire, Erin
    Gardner, Daniel
    Bush, Adam M.
    Detterich, Jon
    Khoo, Michael
    Meiselman, Herbert J.
    Wood, John C.
    Berdoukas, Vasilios
    Coates, Thomas D.
    BLOOD, 2012, 120 (21)
  • [48] The influence of asthma on the incidence of acute chest syndrome and vaso-occlusive pain events in patients with sickle cell disease
    Alcasabas, AP
    Whitten-Shurney, W
    Hamre, M
    Thomas, R
    Sarnaik, S
    PEDIATRIC RESEARCH, 2003, 53 (04) : 277A - 278A
  • [49] Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? A mixed methods evaluation
    Kato-Lin, Yi-Chin
    Krishnamurti, Lakshmanan
    Padman, Rema
    Seltman, Howard J.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2014, 83 (11) : 814 - 824
  • [50] Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease
    Weaver, Salome Bwayo
    Rungkitwattanakul, Dhakrit
    Singh, Divita
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (01) : 139 - 148